Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) [Data Report]
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Orgel, R., Wojdyla, D., Huberman, D., Halperin, J. L., Breithardt, G., Singer, D. E., Fox, K. A. A., Hankey, G. J., Mahaffey, K. W., Jones, W. S., Patel, M. R. Tags: Arrhythmias, Embolism Data Report Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Cardiovascular | Heart | Stroke | Vitamins